ArticleFrontiers in cellular and infection microbiology2026
The value of serum CARDS toxin and NETs formation in children with MPP.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiopulmonary Distress Syndrome Toxin (CARDS TX) is a key virulence factor of Methods: Children hospitalized at Henan Children's Hospital in 2023 with MPP were enrolled and divided into the GMPP group and SMPP group. Serum levels of CARDS TX, citrullinated histone 3 (CitH3) and myeloperoxidase (MPO), were measured in both groups. Comparative analysis of marker levels between groups was conducted. Diagnostic utility for identifying SMPP was evaluated using logistic regression analysis and receiver operating characteristic ROC curves. Results: A total of 147 children with mycoplasma pneumonia were included in this study, among which 74 were in the SMPP group and 73 were in the GMPP group. The levels of serum CARDS TX, MPO, and CitH3 in the SMPP group were significantly higher than those in the GMPP group. The levels of serum CARDS TX, MPO, and CitH3 were significantly positively correlated with SMPP, with correlation coefficients of 0.433, 0.357, and 0.396 respectively. The results of multivariate logistic analysis showed that CARDS TX, MPO, and CitH3 were risk factors for SMPP. The AUC of serum CARDS TX, MPO, and CitH3 levels for predicting SMPP were 0.750, 0.706, and 0.729 respectively, with cut-off values of 7.9 pg/ml, 181.16 ng/ml, and 150.38 ng/ml. Conclusion: The elevated levels of serum CARDS TX, MPO, and CitH3 are independent risk factors for SMPP, and these three indicators have good predictive value for SMPP. CARDS TX secreted by MP may contribute to SMPP development by inducing excessive NET formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.